Abstract
Backgroung Cervical cancer (CC) is one of the common gynecological malignancies, which has a serious negative impact on the quality of life of patients, and brings huge economic pressure and burden to society. The most effective treatment for CC has become an important issue worldwide.
Method In order to determine the current research hotspots and development trends in a particular field, we conducted a bibliometric analysis of the top 100 cited papers. To achieve this, we searched for the top 100 most cited papers on the Science Citation Index Expanded (SCI Expanded) on the Web of Science (WOS), based on the CCS (citation count score). We then reviewed relevant literature from different years, countries/regions, institutions, authors, keywords, and references. Using VOS viewer and Cite Space software, we constructed a knowledge map, and finally compiled the relevant information we retrieved from the literature using Excel. Through this process, we were able to make predictions about the current focus and trends in the field.
Results Between 2013 and 2023, numerous journals published the top 100 cited research papers. The International Agency for Research on Cancer and the American Cancer Society were the most cited institutions. The United States contributed the most papers, followed by France and England. The top 5 keyword co-occurrences were cervical cancer, women, human papillomavirus, United States, and colorectal cancer. Cluster analysis results suggest that future research in CCS may focus on prophylaxis and HPV vaccination.
Conclusion Bibliometric analysis can quickly and intuitively identify the focus and boundaries of cervical cancer research. Our findings suggest that prophylaxis and HPV vaccination may be the focus and trend for future research on cervical cancer.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
As this article is a visual analysis summary of previously published articles, it does not need to pass ethical review.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All files are available from the database.
Abbreviations
- CCS
- cervical cancer screening
- CC
- cervical cancer
- IF
- impact factor
- RCT
- randomized controlled trial
- WoSCC
- Web of Science Core Collection.
